UDG Healthcare plc announced the appointment of Jez Moulding as chief operating officer of UDG Healthcare plc and Executive Vice President of Ashfield with effect from May 2, 2017. Jez will oversee the Ashfield Division globally and will also have responsibility for Group IT, Quality, Compliance, Strategy and Communications as part of his role as COO of UDG Healthcare plc. The Sharp and Aquilant divisions will continue to report directly to Brendan McAtamney, CEO of UDG Healthcare plc. Jez brings extensive international pharmaceutical experience to UDG having spent 18 years at Sanofi, holding numerous senior leadership positions across the globe, in the UK, France, South Africa, Korea, Australia, Japan and the US. In his most recent role as Senior Vice President and North America Region Head for Diabetes and Cardiovascular, he was responsible for 3,500 employees and sales of over $5 billion. Prior to joining Sanofi in 1999, Jez held a variety of positions at Astra Pharmaceuticals and Winchester Pharmaceuticals in the UK.